Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| SAGE THERAPEUTICS | 3 | 17 | +6,09 % | ||
| KINIKSA PHARMACEUTICALS | 3 | 4 | - | ||
| BIOCRYST PHARMACEUTICALS | 3 | 3 | +0,78 % | ||
| SEATTLE GENETICS | 3 | 3 | 0,00 % | ||
| MOMENTA PHARMACEUTICALS | 3 | 3 | 0,00 % | ||
| AURINIA PHARMACEUTICALS | 2 | 27 | -1,25 % | ||
| REGENERON PHARMACEUTICALS | 2 | 17 | +1,04 % | ||
| AMGEN | 2 | 16 | -0,17 % | ||
| BLUEBIRD BIO | 2 | 16 | +2,80 % | ||
| MACROGENICS | 2 | 3 | -3,49 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17:08 | Can Sanofi and Regeneron's Dupixent steal half of a $21B eczema market? Not so fast: analyst | 1 | FiercePharma | ||
| 16:58 | Seattle Genetics: A Prudent Growth Story | 1 | Seeking Alpha | ||
| 16:46 | Aurelius bearish on Neurocrine Biosciences | 15 | Seeking Alpha | ||
| 16:42 | SABCS: Seattle Genetics hails 'stunning' tucatinib breast cancer data | 1 | FierceBiotech | ||
| 16:42 | SABCS: MacroGenics' margetuximab posts OS gains in specific metastatic breast cancer patients | 1 | FierceBiotech | ||
| 16:10 | MacroGenics, Inc.: MacroGenics Presents Results from the SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer at the San ... | 3 | GlobeNewswire (USA) | ||
| 16:10 | Sage Therapeutics up 9% on insider buys | 2 | Seeking Alpha | ||
| 14:58 | Synlogic up 6% premarket on advancement of PKU candidate | - | Seeking Alpha | ||
| 14:58 | Kiniksa Pharma up 7% premarket on Kite collaboration | - | Seeking Alpha | ||
| 14:47 | ProQR Therapeutics N.V. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 14:34 | Kite and Kiniksa Pharmaceuticals Announce Clinical Collaboration Evaluating Investigational Combination of Yescarta and Mavrilimumab in Relapsed or Refractory Large B-Cell Lymphoma | 93 | Business Wire | -- Phase 2 study will Examine the Effect of Mavrilimumab on the Clinical Profile of Yescarta --
Kite, a Gilead Company (Nasdaq: GILD), and Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) ("Kiniksa")... ► Artikel lesen | |
| 14:34 | Kiniksa Pharmaceuticals, Ltd.: Kite and Kiniksa Pharmaceuticals Announce Clinical Collaboration Evaluating Investigational Combination of Yescarta and ... | - | GlobeNewswire (USA) | ||
| 14:17 | Healthpeak Amends & Extends Lease With Amgen in San Francisco | - | Zacks | ||
| 13:42 | Dermira secures FDA fast track status for lebrikizumab in atopic dermatitis | 1 | Pharmaceutical Business Review | ||
| 13:35 | BIOCRYST PHARMACEUTICALS INC - 8-K, Current Report | - | SEC Filings | ||
| 13:34 | BioCryst files U.S. application for berotralstat for HAE | 2 | Seeking Alpha | ||
| 13:22 | Is Rigel Pharmaceuticals Stock a Buy? | 1 | The Motley Fool | ||
| 13:22 | BioCryst submits NDA for BCX7353 | 1 | Seeking Alpha | ||
| 13:17 | PROTEOSTASIS THERAPEUTICS, INC. - 8-K, Current Report | 7 | SEC Filings | ||
| 13:10 | Rocket Pharma down 7% premarket on pricing equity offering | - | Seeking Alpha |
Seite:
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
